Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis in mice

Jung Eun Jang, Han‐Sol Park, Hyun Ju Yoo, In‐Jeoung Baek, Ji Eun Yoon, Myoung Seok Ko, Ah‐Ram Kim, Hyoun Sik Kim, Hye‐Sun Park, Seung Eun Lee, Seung‐Whan Kim, Su Jung Kim, Jaechan Leem, Yu Mi Kang, Min Kyo Jung, Chan‐Gi Pack, Chong Jai Kim, Chang Ohk Sung, In‐Kyu Lee, Joong‐Yeol Park, José C. Fernández‐Checa, Eun Hee Koh, Ki‐Up Lee – 10 January 2017 – Free cholesterol (FC) accumulation in the liver is an important pathogenic mechanism of nonalcoholic steatohepatitis (NASH).

Value‐based care in hepatology

Mario Strazzabosco, John I. Allen, Elizabeth O. Teisberg – 10 January 2017 – The migration from legacy fee‐for‐service reimbursement to payments linked to high‐value health care is accelerating in the United States because of new legislation and redesign of payments from the Centers for Medicare and Medicaid Services. Because patients with chronic diseases account for substantial use of health care resources, payers and health systems are focusing on maximizing the value of care for these patients.

Value‐based care in hepatology

Mario Strazzabosco, John I. Allen, Elizabeth O. Teisberg – 10 January 2017 – The migration from legacy fee‐for‐service reimbursement to payments linked to high‐value health care is accelerating in the United States because of new legislation and redesign of payments from the Centers for Medicare and Medicaid Services. Because patients with chronic diseases account for substantial use of health care resources, payers and health systems are focusing on maximizing the value of care for these patients.

Subscribe to